Comorbidity of insomnia and depression

Sleep Medicine Reviews

Volumn 14, Issue 1, 2010, Pages 35-46

  Staner, Luc ^a  

^a FORENAP   (France)

Author keywords

Antidepressant; Comorbidity; Depression; Insomnia; Non REM sleep; REM sleep

Indexed keywords

AGOMELATINE; AMFEBUTAMONE; AMITRIPTYLINE; CHLORDIAZEPOXIDE; CLONAZEPAM; DOXEPIN; ESZOPICLONE; FLUOXETINE; FLUVOXAMINE; IPRINDOLE; LORMETAZEPAM; MIANSERIN; MIRTAZAPINE; NEFAZODONE; NOMIFENSINE; TIANEPTINE; TRAZODONE; TRIAZOLAM; TRIMIPRAMINE; ZALEPLON; ZOLPIDEM;

AROUSAL; COGNITIVE THERAPY; COMORBIDITY; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DRUG EFFECT; DRUG EFFICACY; ELECTROENCEPHALOGRAM; HOMEOSTASIS; HUMAN; INSOMNIA; LOW DRUG DOSE; MAJOR DEPRESSION; NONREM SLEEP; PSYCHOPHARMACOTHERAPY; PSYCHOTHERAPY; REM SLEEP; REVIEW; SLEEP TIME; TREATMENT OUTCOME;

BEHAVIOR THERAPY; COMBINED MODALITY THERAPY; COMORBIDITY; DEPRESSIVE DISORDER; ELECTROENCEPHALOGRAPHY; HUMANS; HYPNOTICS AND SEDATIVES; SLEEP INITIATION AND MAINTENANCE DISORDERS; SLEEP, REM;

EID: 72649103899     PISSN: 10870792     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.smrv.2009.09.003     Document Type: Review

References (228)

1. Ohayon M.M. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev 6 (2002) 97-111
2. Morin C.M., and Gramling S.E. Sleep patterns and aging: comparison of older with and without insomnia complaints. Psychol Aging 4 (1989) 290-294
3. Edinger J.D., Fins A.I., Glenn D.M., Sullivan Jr. R.J., Bastian L.A., Marsh G.R., et al. Insomnia and the eye of the beholder: are there clinical markers of objective sleep disturbances among adults with and without insomnia complaints?. J Consult Clin Psychol 68 (2000) 586-593
4. Katz D.A., and McHorney C.A. Clinical correlates of insomnia in patients with chronic illness. Arch Intern Med 158 (1998) 1099-1107
5. Lautenbacher S., Kundermann B., and Krieg J.C. Sleep deprivation and pain perception. Sleep Med Rev 10 (2006) 357-369
6. Scott J.P., McNaughton L.R., and Polman R.C. Effects of sleep deprivation and exercise on cognitive, motor performance and mood. Physiol Behav 87 (2006) 396-408
7. Van Dongen H.P., Maislin G., Mullington J.M., and Dinges D.F. The cumulative cost of additional wakefulness: dose-response effects on neurobehavioral functions and sleep physiology from chronic sleep restriction and total sleep deprivation. Sleep 26 (2003) 117-126
8. Soldatos C.R. Insomnia in relation to depression and anxiety: epidemiologic considerations. J Psychosom Res 38 Suppl. 1 (1994) 3-8
9. Riemann D. Insomnia and comorbid psychiatric disorder. Sleep Med 8 Suppl. 4 (2007) S15-S20
10. Ohayon M.M., Caulet M., and Lemoine P. Comorbidity of mental and insomnia disorders in the general population. Compr Psychiatry 39 (1998) 185-197
11. Hamilton M. Frequency of symptoms in melancholia (depressive illness). Br J Psychiatry 154 (1989) 201-206
12. Tsuno N., Besset A., and Ritchie K. Sleep and depression. J Clin Psychiatry 66 (2005) 1254-1269
13. Yates W.R., Mitchell J., Rush A.J., Trivedi M., Wisniewski S.R., Warden D., et al. Clinical features of depression in outpatients with and without co-occurring general medical conditions in STAR*D: confirmatory analysis. Prim Care Companion J Clin Psychiatry 9 (2007) 7-15
14. Breslau N., Roth T., Rosenthal L., and Andreski P. Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adults. Biol Psychiatry 39 (1996) 411-418
15. Stewart R., Besset A., Bebbington P., Brugha T., Lindesay J., Jenkins R., et al. Insomnia comorbidity and impact and hypnotic use by age group in a national survey population aged 16 to 74 years. Sleep 29 (2006) 1391-1397
16. Quera-Salva M.A., Orluc A., Goldenberg F., and Guilleminault C. Insomnia and use of hypnotics: study of a French population. Sleep 14 (1991) 386-391
17. Weissman M.M., Greenwald S., Nino-Murcia G., and Dement W.C. The morbidity of insomnia uncomplicated by psychiatric disorders. Gen Hosp Psychiatry 19 (1997) 245-250
18. Nierenberg A.A., Keefe B.R., Leslie V.C., Alpert J.E., Pava J.A., Worthington III J.J., et al. Residual symptoms in depressed patients who respond acutely to fluoxetine. J Clin Psychiatry 60 (1999) 221-225
19. Fava M., McCall W.V., Krystal A., Wessel T., Rubens R., Caron J., et al. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder. Biol Psychiatry 59 (2006) 1052-1060
20. Carney C.E., Segal Z.V., Edinger J.D., and Krystal A.D. A comparison of rates of residual insomnia symptoms following pharmacotherapy or cognitive-behavioral therapy for major depressive disorder. J Clin Psychiatry 68 (2007) 254-260
21. Ford D.E., and Kamerow D.B. Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention?. JAMA 262 (1989) 1479-1484
22. Chang P.P., Ford D.E., Mead L.A., Cooper-Patrick L., and Klag M.J. Insomnia in young men and subsequent depression. The Johns Hopkins Precursors Study. Am J Epidemiol 146 (1997) 105-114
23. Buysse D.J., Angst J., Gamma A., Ajdacic V., Eich D., and Rössler W. Prevalence, course, and comorbidity of insomnia and depression in young adults. Sleep 31 (2008) 473-480
24. Reynolds III C.F., Frank E., Houck P.R., Mazumdar S., Dew M.A., Cornes C., et al. Which elderly patients with remitted depression remain well with continued interpersonal psychotherapy after discontinuation of antidepressant medication?. Am J Psychiatry 154 (1997) 958-962
25. Van Londen L., Molenaar R.P., Goekoop J.G., Zwinderman A.H., and Rooijmans H.G. Three- to 5-year prospective follow-up of outcome in major depression. Psychol Med 28 (1998) 731-735
26. Thase M.E., Rush A.J., Manber R., Kornstein S.G., Klein D.N., Markowitz J.C., et al. Differential effects of nefazodone and cognitive behavioral analysis system of psychotherapy on insomnia associated with chronic forms of major depression. J Clin Psychiatry 63 (2002) 493-500
27. Mouchabac S., Ferreri M., Cabanac F., and Bitton M. Residual symptoms after a treated major depressive disorder: a survey among private psychiatrists. Encephale 29 (2003) 306-312
28. Jindal R.D., and Thase M.E. Treatment of insomnia associated with clinical depression. Sleep Med Rev 8 (2004) 19-30
29. Krystal A.D., Thakur M., and Roth T. Sleep disturbance in psychiatric disorders: effects on function and quality of life in mood disorders, alcoholism, and schizophrenia. Ann Clin Psychiatry 20 (2008) 39-46
30. NIH. National Institutes of health state of the science conference statement: manifestations and management of chronic insomnia in adults. Sleep 28 (2005) 1049-1057
31. Feinstein A.R. The pre-therapeutic classification of co-morbidity in chronic disease. J Chronic Dis 23 (1970) 455-468
32. Neale M.C., and Kendler K.S. Models of comorbidity for multifactorial disorders. Am J Hum Genet 57 (1995) 935-953
33. Perlis M.L., Smith M.T., and Pigeon R.W. Etiology and pathophysiology of insomnia. In: Kryger M.H., Roth T., and Dement W.C. (Eds). Principles and practice of sleep medicine. 4th ed. (2005), Elsevier Saunders, Philadelphia 714-725
34. Belmaker R.H., and Agam G. Major depressive disorder. N Engl J Med 358 (2008) 55-68
35. Angold A., Costello E.J., and Erkanli A. Comorbidity. J Child Psychol Psychiatry 40 (1999) 57-87
36. American Psychiatric Association (APA). Diagnostic and statistical manual of mental disorder. 4th ed. (2000), APA, Washington DC Text Revision
37. World Health Organisation (WHO). International classification of diseases. 10th ed. (1993), WHO, Genève (ICD-10)
38. Caron C., and Rutter M. Comorbidity in child psychopathology: concepts, issues and research strategies. J Child Psychol Psychiatry 32 (1991) 1063-1080
39. Maser J.D., Patterson T., and Cassano G.B. Spectrum and nosology: implications for DSM-V. Conceptual underpinnings and empirical support for the mood spectrum. Psychiatr Clin North Am 25 (2002) 855-885
40. Skodol A.E. Problems in differential diagnosis: from DSM-III to DSM-III-R in clinical practice (1989), American Psychiatric Press, Washington DC
41. Kessler R.C., McGonagle K.A., Zhao S., Nelson C.B., Hughes M., Eshleman C., et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry 51 (1994) 8-14
42. Wittchen H.U., Nelson C.B., and Lachner G. Prevalence of mental disorders and psychosocial impairments in adolescents and young adults. Psychol Med 28 (1998) 109-126
43. Maj M. "Psychiatric comorbidity": an artefact of current diagnostic systems?. Br J Psychiatry 186 (2005) 182-184
44. American Academy of Sleep Medicine (AASM). The international classification of sleep disorders. Diagnostic and coding manual. 2nd ed. (2005), AASM, Westchester, Illinois American Sleep Disorder Association
45. Edinger J.D., Bonnet M.H., Bootzin R.R., Doghramji K., Dorsey C.M., Espie C.A., et al. American Academy of Sleep Medicine Work Group. Derivation of research diagnostic criteria for insomnia: report of an American Academy of Sleep Medicine Work Group. Sleep 27 (2004) 1567-1596
46. Krishnan K.R., Delong M., Kraemer H., Carney R., Spiegel D., Gordon C., et al. Comorbidity of depression with other medical disease in the elderly. Biol Psychiatry 52 (2002) 559-588
47. Kraemer H.C., Wilson K.A., and Hayward C. Lifetime prevalence and pseudocomorbidity in psychiatric research. Arch Gen Psychiatry 63 (2006) 604-608
48. Schuckit M.A., Smith T.L., Danko G.P., Pierson J., Trim R., Nurnberger J.I., et al. A comparison of factors associated with substance-induced versus independent depressions. J Stud Alcohol Drugs 68 (2007) 805-812
49. Wang J., and Patten S.B. A prospective study of sex-specific effects of major depression on alcohol consumption. Can J Psychiatry 46 (2001) 422-425
50. Fu Q., Heath A.C., Bucholz K.K., Nelson E., Goldberg J., Lyons M.J., et al. Shared genetic risk of major depression, alcohol dependence, and Marijuana dependence. Contribution of antisocial personality disorder in men. Arch Gen Psychiatry 59 (2002) 1125-1132
51. Wang J.C., Hinrichs A.L., Stock H., Budde J., Allen R., Bertelsen S., et al. Evidence of common and specific genetic effects: association of the muscarinic acetylcholine receptor M2 (CHRM2) gene with alcohol dependence and major depressive syndrome. Hum Mol Genet 13 (2004) 1903-1911
52. Ohayon M.M., and Roth T. Place of chronic insomnia in the course of depressive and anxiety disorders. J Psychiatr Res 37 (2003) 9-15
53. Chilcoat H.D., and Breslau N. Investigations of causal pathways between PTSD and drug use disorders. Addict Behav 23 (1998) 827-840
54. Johnson E.O., Roth T., and Breslau N. The association of insomnia with anxiety disorders and depression: exploration of the direction of risk. J Psychiatr Res 40 (2006) 700-708
55. Gregory A.M., Rijsdijk F.V., Lau J.F., Dahl R.E., and Eley T.C. The direction of longitudinal associations between sleep problems and depression symptoms: a study of twins aged 8 and 10 years. Sleep 32 (2009) 189-199
56. Casper R.C., Katz M.M., Bowden C.L., Davis J.M., Koslow S.H., and Hanin I. The pattern of physical symptom changes in major depressive disorder following treatment with amitriptyline or imipramine. J Affect Disord 31 (1994) 151-164
57. Pigeon W.R., Hegel M., Unützer J., Fan M.Y., Sateia M.J., Lyness J.M., et al. Is insomnia a perpetuating factor for late-life depression in the IMPACT cohort?. Sleep 31 (2008) 481-488
58. Dombrovski A.Y., Cyranowski J.M., Mulsant B.H., Houck P.R., Buysse D.J., Andreescu C., et al. Which symptoms predict recurrence of depression in women treated with maintenance interpersonal psychotherapy?. Depress Anxiety 25 (2008) 1060-1066
59. Roane B.M., and Taylor D.J. Adolescent insomnia as a risk factor for early adult depression and substance abuse. Sleep 31 (2008) 1351-1356
60. Roberts R.E., Shema S.J., Kaplan G.A., and Strawbridge W.J. Sleep complaints and depression in an aging cohort: a prospective perspective. Am J Psychiatry 157 (2000) 81-88
61. Perlis M.L., Giles D.E., Buysse D.J., Tu X., and Kupfer D.J. Self-reported sleep disturbance as a prodromal symptom in recurrent depression. J Affect Disord 42 (1997) 209-212
62. Wu J.C., and Bunney W.E. The biological basis of an antidepressant response to sleep deprivation and relapse: review and hypothesis. Am J Psychiatry 147 (1990) 14-21
63. Meerlo P., Sgoifo A., and Suchecki D. Restricted and disrupted sleep: effects on autonomic function, neuroendocrine stress systems and stress responsivity. Sleep Med Rev 12 (2008) 197-210
64. Novati A., Roman V., Cetin T., Hagewoud R., den Boer J.A., Luiten P.G., et al. Chronically restricted sleep leads to depression-like changes in neurotransmitter receptor sensitivity and neuroendocrine stress reactivity in rats. Sleep 31 (2008) 1579-1585
65. Meltzer L.J., and Mindell J.A. Impact of a child's chronic illness on maternal sleep and daytime functioning. Arch Intern Med 166 (2006) 1749-1755
66. Spiegel K., Leproult R., and Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet 354 (1999) 1435-1439
67. Riemann D., Spiegelhalder K., Feige B., Voderholzer U., Berger M., Perlis M., et al. The hyperarousal model of insomnia: a review of the concept and its evidence. Sleep Med Rev 14 1 (2010) 19-31
68. Woody G.E., Mc Lellan A.T., and O'Brien C.P. Development of psychiatric illness in drug abusers. Possible role of drug preference. N Engl J Med 301 (1979) 1310-1314
69. Smith B.D., and Salzman C. Do benzodiazepines cause depression?. Hosp Community Psychiatry 42 (1991) 1101-1102
70. Ashton H. Protracted withdrawal syndromes from benzodiazepines. J Subst Abuse Treat 8 (1991) 19-28
71. Neckelman D., Mykletun A., and Dahl A.A. Chronic insomnia as a risk factor for developing anxiety and depression. Sleep 30 (2007) 873-880
72. Falconer D.S. Inheritance of liability to certain diseases estimated from incidence among relatives. Ann Hum Genet 29 (1965) 51-76
73. Krueger R.F., and Markon K.E. Reinterpreting comorbidity: a model-based approach to understanding and classifying psychopathology. Annu Rev Clin Psychol 2 (2006) 111-133
74. Buysse D.J. Overview of insomnia: definitions, epidemiology, differential diagnosis and assessment. In: Kryger M.H., Roth T., and Dement W.C. (Eds). Principles and practice of sleep medicine. 4th ed. (2005), Elsevier Saunders, Philadelphia 702-713
75. Dobson K., and Dozois D. Risk factors in depression (2008), Elsevier, New York 510 pp.
76. Buysse D.J., and Kupfer D.J. Diagnostic and research applications of electroencephalographic sleep studies in depression: conceptual and methodological issues. J Nerv Ment Dis 178 (1990) 405-414
77. Reynolds III C.F., and Kupfer D.J. Sleep research in affective illness: state of the art circa 1987. Sleep 10 (1987) 199-215
78. Gaillard J.M. Chronic primary insomnia: possible physiopathological involvement of slow wave sleep deficiency. Sleep 1 (1978) 133-147
79. Gillin J.C., Duncan W., Pettigrew K.D., Frankel B.L., and Snyder F. Successful separation of depressed, normal, and insomniac subjects by EEG sleep data. Arch Gen Psychiatry 36 (1979) 85-90
80. Lamarche C.H., and Ogilvie R.D. Electrophysiological changes during the sleep onset period of psychophysiological insomniacs, psychiatric insomniacs and normal sleepers. Sleep 20 (1997) 724-733
81. Besset A., Villemin E., Tafti M., and Billiard M. Homeostatic process and spindles in patients with sleep-maintenance insomnia: effect of partial (21 h) sleep deprivation. Electroencephalogr Clin Neurophysiol 107 (1998) 122-132
82. Staner L., Cornette F., Maurice D., Viardot G., Le Bon O., Haba J., et al. Sleep microstructure around sleep onset differentiates major depressive insomnia from primary insomnia. J Sleep Res 12 (2003) 319-330
83. Ho A.P., Gillin J.C., Buchsbaum M.S., Wu J.C., Abel L., and Bunney W.E. Brain glucose metabolism during non-rapid eye movement sleep in major depression. A positron emission tomography study. Arch Gen Psychiatry 53 (1996) 645-652
84. Nofzinger E.A., Price J.C., Meltzer C.C., Buysse D.J., Villemagne V.L., Miewald J.M., et al. Toward a neurobiology of dysfunctional arousal in depression: the relationship between beta EEG power and regional cerebral glucose metabolism during NREM sleep. Psychiatry Res Neuroimaging 98 (2000) 71-91
85. Germain A., Nofzinger E.A., Kupfer D.J., and Buysse D.J. Neurobiology of non-REM sleep in depression: further evidence for hypofrontality and thalamic dysregulation. Am J Psychiatry 161 (2004) 1856-1863
86. Nofzinger E.A., Buysse D.J., Germain A., Carter C., Luna B., Price J.C., et al. Increased activation of anterior paralimbic and executive cortex from waking to rapid eye movement sleep in depression. Arch Gen Psychiatry 61 (2004) 695-702
87. Bonnet M.H., and Arand D.L. 24-Hour metabolic rate in insomniacs and matched normal sleepers. Sleep 18 (1995) 581-588
88. Bonnet M.H., and Arand D.L. Heart rate variability in insomniacs and matched normal sleepers. Psychosom Med 60 (1998) 610-615
89. Johns M.W., Gay T.J., Masterton J.P., and Bruce D.W. Relationship between sleep habits, adrenocortical activity and personality. Psychosom Med 33 (1971) 499-508
90. Vgontzas A.N., Bixler E.O., Lin H.M., Prolo P., Mastorakos G., Vela-Bueno A., et al. Chronic insomnia is associated with nyctohemeral activation of the hypothalamic-pituitary-adrenal axis: clinical implications. J Clin Endocrinol Metab 86 (2001) 3787-3794
91. Rodenbeck A., Huether G., Ruther E., and Hajak G. Interactions between evening and nocturnal cortisol secretion and sleep parameters in patients with severe chronic primary insomnia. Neurosci Lett 324 (2002) 159-163
92. Backhaus J., Junghanns K., and Hohagen F. Sleep disturbances are correlated with decreased morning awakening salivary cortisol. Psychoneuroendocrinology 29 (2004) 1184-1191
93. Riemann D., Klein T., Rodenbeck A., Feige B., Horny A., Hummel R., et al. Nocturnal cortisol and melatonin secretion in primary insomnia. Psychiatry Res 113 (2002) 17-27
94. Varkevisser M., Van Dongen H.P.A., and Kerkhof G.A. Physiologic indexes in chronic insomnia during a constant routine: evidence for general hyperarousal?. Sleep 28 (2005) 1588-1596
95. Chapotot F., Buguet A., Gronfrier C., and Brandenberger G. Hypothalamo-pituitary adrenal axis activity is related to the level of central arousal: effect of sleep deprivation on the association of high-frequency waking electroencephalogram with cortisol release. Neuroendocrinology 73 (2001) 312-321
96. Leproult R., Copinsschi G., Buxton O., and Van Cauter E. Sleep loss results in an elevation of cortisol levels in the next evening. Sleep 20 (1997) 865-870
97. Rodenbeck A., Cohrs S., Jordan W., Huether G., Rüther E., and Hajak G. The sleep-improving effects of doxepin are paralleled by a normalized plasma cortisol secretion in primary insomnia. A placebo-controlled, double-blind, randomized, cross-over study followed by an open treatment over 3 weeks. Psychopharmacology 170 (2003) 423-428
98. Buckley T., Duggal V., and Schatzberg A.F. The acute and post-discontinuation effects of a glucocorticoid receptor (GR) antagonist probe on sleep and the HPA axis in chronic insomnia: a pilot study. J Clin Sleep Med 4 (2008) 235-241
99. Koob G.F. Corticotropin-releasing factor, norepinephrine and stress. Biol Psychiatry 46 (1999) 1167-1180
100. McEwen B.S. Mood disorders and allostatic load. Biol Psychiatry 54 (2003) 200-207
101. Beck A.T. The evolution of the cognitive model of depression and its neurobiological correlates. Am J Psychiatry 165 (2008) 969-977
102. Holsboer F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 23 (2000) 477-501
103. Müller M.B., and Wurst W. Getting closer to affective disorders: the role of the CRH receptor system. Trends Mol Med 10 (2004) 409-415
104. Arango V., Underwood M.D., and Mann J.J. Fewer pigmented locus coeruleus neurons in suicide victims: preliminary results. Biol Psychiatry 39 (1996) 112-120
105. Klimek V., Stockmeier C., Overholser J., Meltzer H.Y., Kalka S., Dilley G., et al. Reduced levels of norepinephrine transporters in the locus coeruleus in major depression. J Neurosci 17 (1997) 8451-8458
106. Bissette G., Klimek V., Pan J., Stockmeier C., and Ordway G. Elevated concentrations of CRF in the locus coeruleus of depressed subjects. Neuropsychopharmacology 28 (2003) 1328-1335
107. Baumann B., Danos P., Diekmann S., Krell D., Bielau H., Geretsegger C., et al. Tyrosine hydroxylase immunoreactivity in the locus coeruleus is reduced in depressed non-suicidal patients but normal in depressed suicide patients. Eur Arch Psychiatry Clin Neurosci 249 (1999) 212-219
108. Gorman J.M., and Sloan R.P. Heart rate variability in depressive and anxiety disorders. Am Heart J 140 4 Suppl. (2000) 77-83
109. Agelink M.W., Klimke A., Cordes J., Sanner D., Kavuk I., Malessa R., et al. A functional-structural model to understand cardiac autonomic nervous system (ANS) dysregulation in affective illness and to elucidate the ANS effects of antidepressive treatment. Eur J Med Res 9 (2004) 37-50
110. Hubain P., Staner L., Dramaix M., Kerkhofs M., Papadimitriou G., Mendlewicz J., et al. The dexamethasone suppression test and sleep electroencephalogram in major depressed inpatients: a multivariate analysis. Biol Psychiatry 43 (1998) 220-229
111. Vgontzas A.N., Tsigos C., Bixler E.O., Stratakis C.A., Zachman K., Kales A., et al. Chronic insomnia and activity of the stress system: a preliminary study. J Psychosom Res 45 1 Spec No. (1998) 21-31
112. Wong M.L., Kling M.A., Munson P.J., Listwack S., Licinio J., Prolo P., et al. Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone. Proc Natl Acad Sci U S A 97 (2000) 325-330
113. Staner L., Duval F., Haba J., Mokrani M.C., and Macher J.P. Disturbances in hypothalamo pituitary adrenal and thyroid axis identify different sleep EEG patterns in major depressed patients. J Psychiatr Res 37 (2003) 1-8
114. Winsky-Sommerer R., Yamanaka A., Diano S., Borok E., Roberts A.J., Sakurai T., et al. Interaction between the corticotropin-releasing factor system and hypocretins (orexins): a novel circuit mediating stress response. J Neurosci 24 (2004) 11439-11448
115. Feng P., Vurbic D., Wu Z., and Strohl K.P. Brain orexins and wake regulation in rats exposed to maternal deprivation. Brain Res 1154 (2007) 163-172
116. Prober D.A., Rihel J., Onah A.A., Sung R.J., and Schier A.F. Hypocretin/orexin overexpression induces an insomnia-like phenotype in zebrafish. J Neurosci 26 (2006) 13400-13410
117. Dingemanse J., Dorffner G., Hajak G., Benes H., Danker-Hopfe H., Polo O., et al. Proof-of-concept study in primary insomnia patients with almorexant (ACT-078573), a dual orexin receptor antagonist. Sleep Biol Rhythms (2007) Worldsleep 07 supplement
118. Salomon R.M., Ripleyb B., Kennedy J.S., Johnson B., Schmidt D., Zeitzer J.M., et al. Diurnal variation of cerebrospinal fluid hypocretin-1 (Orexin-A) levels in control and depressed subjects. Biol Psychiatry 54 (2003) 96-104
119. Brundin L., Björkqvist M., Petersén A., and Träskman-Bendz L. Reduced orexin levels in the cerebrospinal fluid of suicidal patients with major depressive disorder. Eur Neuropsychopharmacol 17 (2007) 573-579
120. Pigeon R.W., and Perlis M.L. Sleep homeostasis in primary insomnia. Sleep Med Rev 10 (2006) 247-254
121. Frankel B.L., Coursey R., Buchbinder R., and Snyder F. Recorded and reported sleep in primary chronic insomnia. Arch Gen Psychiatry 33 (1976) 615-623
122. Reynolds C.F., Taska L.S., Sewitch D.E., Restifo K., Coble P.A., and Kupfer D.J. Persistent psychophysiologic insomnia: preliminary research diagnostic criteria and EEG sleep data. Am J Psychiatry 141 (1984) 804-805
123. Hauri P., and Fisher J. Persistent psychophysiologic (learned) insomnia. Sleep 9 (1986) 38-53
124. Gaillard J.M. Is insomnia a disease of slow wave sleep?. Eur Neurol 14 (1976) 473-484
125. Sewitch D.E. Slow wave sleep deficiency in insomnia: a problem in thermo-downregulation at sleep onset. Psychophysiology 24 (1987) 200-215
126. Krystal A.D., Edinger J.D., Wohlgemuth W.K., and Marsh G.R. NREM sleep EEG frequency spectral correlates of sleep complaints in primary insomnia subtypes. Sleep 25 (2002) 630-640
127. Feige B., Al-Shajlawi A., Nissen C., Voderholzer U., Hornyak M., Spiegelhalder K., et al. Does REM sleep contribute to subjective wake time in primary insomnia? A comparison of polysomnographic and subjective sleep in 100 patients. J Sleep Res 17 (2008) 180-190
128. Perlis M.L., Smith M.T., Orff H.J., Andrews P.J., and Giles D.E. Beta/gamma EEG activity in patients with primary and secondary insomnia and good sleepers controls. Sleep 24 (2001) 110-117
129. Borbely A.A., and Wirz-Justice A. Sleep, sleep deprivation and depression. A hypothesis derived from a model of sleep regulation. Hum Neurobiol 1 (1982) 205-210
130. Staner L., Luthringer R., and Le Bon O. Sleep disturbances in affective disorders. In: Pandi-Perumal S.R., and Monti J.M. (Eds). Clinical pharmacology of sleep (2006), Birkhauser Verlag, Basel 101-124
131. Basheer R., Strecker R.E., Thakkar M.M., and Mc Carley R.W. Adenosine and sleep-wake regulation. Prog Neurobiol 73 (2004) 379-396
132. Porkka-Heiskanen T., Strecker R.E., Thakkar M., Bjorkum A.A., Greene R.W., McCarley R.W., et al. Adenosine: a mediator of the sleep-inducing effects of prolonged wakefulness. Science 276 (1997) 1265-1268
133. Retey J.V., Adam M., Khatami R., Luhmann U.F., Jung H.H., Berger W., et al. A genetic variation in the adenosine A2A receptor gene (ADORA2) contributes to the individual sensitivity to caffeine. Clin Pharmacol Ther 81 (2007) 692-698
134. Hamilton S.P., Slager S.L., De Leon A.B., Heiman G.A., Klein D.F., Hodge S.E., et al. Evidence for genetic linkage between a polymorphism in the adenosine 2A receptor and panic disorder. Neuropsychopharmacology 29 (2004) 558-565
135. Deckert J., Nöthen M.M., Franke P., Delmo C., Fritze J., Knapp M., et al. Systematic mutation screening and association study of the A1 and A2a adenosine receptor genes in panic disorder suggest a contribution of the A2a gene to the development of disease. Mol Psychiatry 3 (1998) 81-85
136. Alsene K., Deckert J., Sand P., and de Wit H. Association between A2a receptor gene polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology 28 (2003) 1694-1702
137. Berk M., Plein H., Ferreira D., and Jersky B. Blunted adenosine A2a receptor function in platelets in patients with major depression. Eur Neuropsychopharmacol 11 (2001) 183-186
138. Herken H., Gurel A., Selek S., Armutcu F., Ozen M.E., Bulut M., et al. Adenosine deaminase, nitric oxide, superoxide dismutase, and xanthine oxidase in patients with major depression: impact of antidepressant treatment. Arch Med Res 38 (2007) 247-252
139. Kaster M.P., Rosa A.O., Rosso M.M., Goulart E.C., Santos A.R., and Rodrigues A.L. Adenosine administration produces an antidepressant-like effect in mice: evidence for the involvement of A1 and A2A receptors. Neurosci Lett 355 (2004) 21-24
140. El Yacoubi M., Ledent C., Parmentier M., Bertorelli R., Ongini E., Costentin J., et al. Adenosine A2A receptor antagonists are potential antidepressants: evidence based on pharmacology and A2A receptor knockout mice. Br J Pharmacol 134 (2001) 68-77
141. Phillis J.W., and Wu P.H. The effect of various centrally active drugs on adenosine uptake by the central nervous system. Comp Biochem Physiol 72C (1982) 179-187
142. Phillis J.W. Potentiation of the action of adenosine on cerebral cortical neurones by the tricyclic antidepressants. Br J Pharmacol 83 (1984) 567-575
143. Zahorodna A., Bijak M., and Hess G. Differential effects of repeated imipramine on hippocampal responsiveness to adenosine and serotonin. Eur Neuropsychopharmacol 12 (2002) 355-360
144. Berger M., van Calker D., and Riemann D. Sleep and manipulations of the sleep-wake rhythm in depression. Acta Psychiatr Scand Suppl. 418 (2003) 83-91
145. Hobson J.A., Pace-Schott E.F., and Stickgold R. Dreaming and the brain: toward a cognitive neuroscience of conscious states. In: Pace Schott E.F., Solms M., Blagrove M., and Harnad S. (Eds). Sleep and dreaming (2003), Cambridge University Press 1-50
146. Datta S., and Maclean R.R. Neurobiological mechanisms for the regulation of mammalian sleep-wake behavior: reinterpretation of historical evidence and inclusion of contemporary cellular and molecular evidence. Neurosci Biobehav Rev 31 (2007) 775-824
147. Riemann D., Berger M., and Voderholzer U. Sleep and depression - results from psychobiological studies: an overview. Biol Psychol 57 (2001) 67-103
148. Ruggiero D.A., Underwood M.D., Rice P.M., Mann J.J., and Arango V. Corticotropic-releasing hormone and serotonin interact in the human brainstem: behavioural implications. Neuroscience 91 (1999) 1343-1354
149. Kirby L.G., Rice K.C., and Valentino R.J. Effects of corticotropin-releasing factor on neuronal activity in the serotoninergic dorsal raphe nucleus. Neuropsychopharmacology 22 (2000) 148-162
150. Lopez J.F., Chalmers D.T., Little K.Y., and Watson S.J. Regulation of serotonin 1a, glucocorticoid and mineralocorticoid receptor in rat and human hippocampus: implications for the neurobiology of depression. Biol Psychiatry 43 (1998) 547-573
151. Wissink S., Meijer O., Pearce D., van Der Burg B., and van Der Saag P.T. Regulation of the rat serotonin-1A receptor gene by corticosteroids. J Biol Chem 275 (2000) 1321-1326
152. Monti J.M., and Monti D. Role of the dorsal raphe nucleus serotonin 5-HT1A receptor in the regulation of sleep. Life Sci 21 (2000) 1999-2012
153. Staner L., Linker T., Toussaint M., Danjou P., Roegel J.C., Luthringer R., et al. Effects of the selective activation of 5-HT3 receptors on sleep: a polysomnographic study in healthy volunteers. Eur Neuropsychopharmacol 11 (2001) 301-305
154. Zobel A.W., Nickel T., Künzel H.E., Ackl N., Sonntag A., Ising M., et al. Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated. J Psychiatr Res 34 (2000) 171-181
155. Chen M.C., Joormann J., Hallmayer J., and Gotlib I.H. Serotonin transporter polymorphism predicts waking cortisol in young girls. Psychoneuroendocrinology (2009) Epub 2009 Jan 5
156. Gotlib I.H., Joormann J., Minor K.L., and Hallmayer J. HPA axis reactivity: a mechanism underlying the associations among 5-HTTLPR, stress, and depression. Biol Psychiatry 63 (2008) 847-851
157. Jabbi M., Korf J., Kema I.P., Hartman C., van der Pompe G., Minderaa R.B., et al. Convergent genetic modulation of the endocrine stress response involves polymorphic variations of 5-HTT, COMT and MAOA. Mol Psychiatry 12 (2007) 483-490
158. Wilhelm K., Mitchell P.B., Niven H., Finch A., Wedgwood L., Scimone A., et al. Life events, first depression onset and the serotonin transporter gene. Br J Psychiatry 188 (2006) 210-215
159. Zalsman G., Huang Y.Y., Oquendo M.A., Burke A.K., Hu X.Z., Brent D.A., et al. Association of a triallelic serotonin transporter gene promoter region (5-HTTLPR) polymorphism with stressful life events and severity of depression. Am J Psychiatry 163 (2006) 1588-1593
160. Schreiber W., Lauer C.J., Krumrey K., Holsboer F., and Krieg J. Cholinergic REM sleep induction test in subjects at high risk for psychiatric disorder. Biol Psychiatry 32 (1992) 79-90
161. Lauer C.J., Modell S., Schreiber W., Krieg J.C., and Holsboer F. Prediction of the development of a first major depressive episode with a rapid eye movement sleep induction test using the cholinergic agonist RS 86. J Clin Psychopharmacol 24 (2004) 356-357
162. Modell S., Ising M., Holsboer F., and Lauer C.J. The Munich vulnerability study on affective disorders: premorbid polysomnographic findings profile of affected high-risk probands. Biol Psychiatry 58 (2005) 694-699
163. Morgenthaler T., Kramer M., Alessi C., Friedman L., Boehlecke B., Brown T., et al. Practice parameters for the psychological and behavioral treatment of insomnia: an update. An american academy of sleep medicine report. Sleep 29 (2006) 1415-1419
164. Schutte-Rodin S., Broch L., Buysse D., Dorsey C., and Sateia M. Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med 4 (2008) 487-504
165. APA Steering Committe on Practice Guidelines. Practice guideline for the treatment of patients with major depressive disorder. 2nd ed. (2005), American Psychiatric Press, Washington DC 78 pp.
166. Millmann R.P., Fogel B.S., McNamara M.E., and Carlisle C.C. Depression as a manifestation of obstructive sleep apnea: reversal with nasal continuous positive pressure. J Clin Psychiatry 50 (1989) 348-351
167. Picchietti D., and Winkelman J.W. Restless legs syndrome, periodic limb movements in sleep, and depression. Sleep 28 (2005) 891-898
168. Berry R.B., and Patel P.B. Effect of zolpidem on the efficacy of continuous positive airway pressure as treatment for sleep apnea. Sleep 29 (2006) 1052-1056
169. Rosenberg R., Roach J.M., Scharf M., and Amato D.A. A pilot study evaluating acute use of eszopiclone in patients with mild to moderate obstructive sleep apnea syndrome. Sleep Med 8 (2007) 464-470
170. Morin C.M., Colecchi C., Stone J., Sood R., and Brink D. Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial. JAMA 281 (1999) 991-999
171. Smith M.T., Perlis M.L., Park A., Smith M.S., Pennington J., Giles D.E., et al. Comparative meta-analysis of pharmacotherapy and behavior therapy for persistent insomnia. Am J Psychiatry 159 (2002) 5-11
172. Perlis M., Aloia M., Millikan A., Boehmler J., Smith M., Greenblatt D., et al. Behavioral treatment of insomnia: a clinical case series study. J Behav Med 23 (2000) 149-161
173. Taylor D.J., Lichstein K.L., Weinstock J., Sanford S., and Temple J.R. A pilot study of cognitive-behavioral therapy of insomnia in people with mild depression. Behav Ther 38 (2007) 49-57
174. Manber R., Edinger J.D., Gress J.L., San Pedro-Salcedo M.G., Kuo T.F., and Kalista T. Cognitive behavioral therapy for insomnia enhances depression outcome in patients with comorbid major depressive disorder and insomnia. Sleep 31 (2008) 489-495
175. Manber R., Rush J., Thase M.E., Arnow B., Klein D., Trivedi M.H., et al. The effects of psychotherapy, nefazodone, and their combination on subjective assessment of disturbed sleep in chronic depression. Sleep 26 (2003) 130-136
176. Doghramji K. Treatment strategies for sleep disturbance in patients with depression. J Clin Psychiatry 64 Suppl. 14 (2003) 24-29
177. Lam R.W. Sleep disturbances and depression: a challenge for antidepressants. Int Clin Psychopharmacol 21 Suppl. 1 (2006) S25-S29
178. Thase M.E. Depression and sleep: pathophysiology and treatment. Dialogues Clin Neurosci 8 (2006) 217-226
179. Blackburn A.B., Karacan I., and Salis P.J. The effects of doxepin hcl on sleep patterns of neurotically depressed patients with sleep disturbances. Sleep Res 4 (1975) 90
180. Scharf M.B., McDannold M., Zaretsky N., Spinner O., Stover R., Berkowitz D.V., et al. Evaluation of sleep architecture and cyclic alternating pattern rates in depressed insomniac patients treated with nefazodone hydrochloride. Am J Ther 6 (1999) 77-82
181. Shen J., Kennedy S.H., Levitan R.D., Kayumov L., and Shapiro C.M. The effects of nefazodone on women with seasonal affective disorder: clinical and polysomnographic analyses. J Psychiatry Neurosci 30 (2005) 11-16
182. Ruigt G.S., Kemp B., Groenhout C.M., and Kamphuisen H.A. Effect of the antidepressant Org 3770 on human sleep. Eur J Clin Pharmacol 38 (1990) 551-554
183. Winokur A., DeMartinis III N.A., McNally D.P., Gary E.M., Cormier J.L., and Gary K.A. Comparative effects of mirtazapine and fluoxetine on sleep physiology measures in patients with major depression and insomnia. J Clin Psychiatry 64 (2003) 1224-1229
184. Ware J.C., Brown F.W., Moorad P.J., Pittart J.T., and Cobart B. Effects on sleep: a double-blind study comparing trimipramine to imipramine in depressed insomniac patients. Sleep 12 (1989) 537-549
185. Feuillade P., Pringuey D., Belogou J.L., Robert P., and Darcourt G. Trimipramine: acute and lasting effects on sleep in healthy and major depressive subjects. J Affect Disord 24 (1992) 135-146
186. Roth T., Zorick F., Wittig R., McLenaghan A., and Roehrs T. The effect of doxepin HCL on sleep and depression. J Clin Psychiatry 43 (1982) 366-368
187. Mendlewicz J., Kempenaers C., and De Martelaer V. Sleep EEG and amitriptyline treatment in depressed inpatients. Biol Psychiatry 30 (1991) 691-702
188. Saper C.B., Scammell T.E., and Lu J. Hypothalamic regulation of sleep and circadian rhythms. Nature 437 (2005) 1257-1263
189. Jones B.E. From waking to sleeping: neuronal and chemical substrates. Trends Pharmacol Sci 26 (2005) 578-586
190. Destexhe A., Hughes S.W., Rudolph M., and Crunelli V. Are corticothalamic 'up' states fragments of wakefulness?. Trends Neurosci 30 (2007) 334-342
191. Mouret J., Lemoine P., Minuit M.P., Sanchez P., and Taillard J. Effects of trazodone on the sleep of depressed subjects-a polygraphic study. Psychopharmacology 95 (1988) S37-S43
192. Scharf M.B., and Sachais B.A. Sleep laboratory evaluation of the effects and efficacy of trazodone in depressed insomniac patients. J Clin Psychiatry 51 Suppl. (1990) 13-17
193. Saletu-Zyhlarz G.M., Abu-Bakr M.H., Anderer P., Gruber G., Mandl M., Strobl R., et al. Insomnia in depression: differences in objective and subjective sleep and awakening quality to normal controls and acute effects of trazodone. Prog Neuropsychopharmacol Biol Psychiatry 26 (2002) 249-260
194. Hicks J.A., Argyropoulos S.V., Rich A.S., Nash J.R., Bell C.J., Edwards C., et al. Randomised controlled study of sleep after nefazodone or paroxetine treatment in out-patients with depression. Br J Psychiatry 180 (2002) 528-535
195. Rush J.A., Armitage R., Gillin J.C., Yonkers K.A., Winokur A., Moldofsky H., et al. Comparative effects of nefazodone and fluoxetine on sleep in outpatients with major depression. Biol Psychiatry 44 (1998) 3-14
196. Mendlewicz J., Dunbar G.C., and Hoffman G. Changes in sleep EEG architecture during the treatment of depressed patients with mianserine. Acta Psychiatr Scand 320 Suppl. (1985) 26-29
197. Schmid D.A., Wichniak A., Uhr M., Ising M., Brunner H., Held K., et al. Changes of sleep architecture, spectral composition of sleep EEG, the nocturnal secretion of cortisol, ACTH, GH, prolactin, melatonin, ghrelin, and leptin, and the DEX-CRH test in depressed patients during treatment with mirtazapine. Neuropsychopharmacology 31 (2006) 832-844
198. Schittecatte M., Dumont F., Machowski R., Cornil C., Lavergne F., and Wilmotte J. Effects of mirtazapine on sleep polygraphic variables in major depression. Neuropsychobiology 46 (2002) 197-201
199. Shen J., Chung S.A., Kayumov L., Moller H., Hossain N., Wang X., et al. Polysomnographic and symptomatological analyses of major depressive disorder patients treated with mirtazapine. Can J Psychiatry 51 (2006) 27-34
200. Quera Salva M.A., Vanier B., Laredo J., Hartley S., Chapotot F., Moulin C., et al. Major depressive disorder, sleep EEG and agomelatine: an open-label study. Int J Neuropsychopharmacol 10 (2007) 691-696
201. Staner L, Staner C, Luthringer R. Antidepressant-induced alteration of sleep EEG. In: Pandi-Perumal SR, Kramer M, (eds). Sleep and mental illness. Cambridge University Press 2010; in press.
202. Wilson S.J., Bell C., Coupland N.J., and Nutt D.J. Sleep changes during long-term treatment of depression with fluvoxamine-a home-based study. Psychopharmacology 149 (2000) 360-365
203. Dzirasa K., Ribeiro S., Costa R., Santos L.M., Lin S.C., Grosmark A., et al. Dopaminergic control of sleep-wake states. J Neurosci 26 (2006) 10577-10589
204. Dahan L., Astier B., Vautrelle N., Urbain N., Kocsis B., and Chouvet G. Prominent burst firing of dopaminergic neurons in the ventral tegmental area during paradoxical sleep. Neuropsychopharmacology 32 (2007) 1232-1241
205. Monti J.M., and Monti D. The involvement of dopamine in the modulation of sleep and waking. Sleep Med Rev 11 (2007) 113-133
206. Turner E.H., Matthews A.M., Linardatos E., Tell R.A., and Rosenthal R. Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med 358 (2008) 252-260
207. Heiligenstein J.H., Faries D.E., Rush A.J., Andersen J.S., Pande A.C., Roffwarg H.P., et al. Latency to rapid eye movement sleep as a predictor of treatment response to fluoxetine and placebo in nonpsychotic depressed outpatients. Psychiatry Res 52 (1994) 327-339
208. Coble P.A., Kupfer D.J., Spiker D.G., Neil J.F., and Mc Partland R.J. EEG sleep in primary depression. A longitudinal placebo study. J Affect Disord 1 (1979) 131-138
209. Thase M.E., Simons A.D., and Reynolds III C.F. Abnormal electroencephalographic sleep profiles in major depression. Association with response to cognitive behavior therapy. Arch Gen Psychiatry 53 (1996) 99-108
210. Buysse D.J., Tu X.M., Cherry C.R., Begley A.E., Kowalski J., Kupfer D.J., et al. Pretreatment REM sleep and subjective sleep quality distinguish depressed psychotherapy remitters and nonremitters. Biol Psychiatry 45 (1999) 205-213
211. Ott G.E., Rao U., Nuccio I., Lin K.M., and Poland R.E. Effect of bupropion-SR on REM sleep: relationship to antidepressant response. Psychopharmacology 165 (2002) 29-36
212. Murck H., Nickel T., Künzel H., Antonijevic I.A., Schill J., Zobel A., et al. State markers of depression in sleep EEG: dependency on drug and gender in patients treated with tianeptine or paroxetine. Neuropsychopharmacology 28 (2003) 348-358
213. Tatsumi M., Groshan K., Blakely R.D., and Richelson E. Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol 340 (1997) 249-258
214. Staner L., and Mendlewicz J. Effect of a single dose of tianeptine in healthy volunteer on sleep electrophysiological parameters. Eur Psychiatry 9 Suppl. 1 (1994) 141
215. Nofzinger E.A., Reynolds III C.F., Thase M.E., Frank E., Jennings J.R., Fasiczka A.L., et al. REM sleep enhancement by bupropion in depressed man. Am J Psychiatry 152 (1995) 274-276
216. Svendsen K., and Christensen P.G. Duration of REM sleep latency as predictor of effect of antidepressant therapy. A preliminary report. Acta Psychiatr Scand 64 (1981) 238-243
217. Rush A.J., Erman M.K., Schlesser M.A., Roffwarg H.P., Vasavada N., Khatami M., et al. Alprazolam vs amitriptyline in depressions with reduced REM latencies. Arch Gen Psychiatry 42 (1985) 1154-1159
218. Rush A.J., Giles D.E., Jarrett R.B., Feldman-Koffler F., Debus J.R., Weissenburger J., et al. Reduced REM latency predicts response to tricyclic medication in depressed outpatients. Biol Psychiatry 26 (1989) 61-72
219. Akiskal H.S., Rosenthal T.L., Haykal R.F., Lemmi H., Rosenthal R.H., and Scott-Strauss A. Characterological depressions: clinical and sleep EEG findings separating subaffective dysthymias from character spectrum disorders. Arch Gen Psychiatry 37 (1980) 777-783
220. Kupfer D.J., Spiker D.G., Coble P.A., Neil J.F., Ulrich R., and Shaw D.H. Sleep and treatment prediction in endogenous depression. Am J Psychiatry 138 (1981) 429-434
221. Thase M.E., Himmelhoch J.M., Mallinger A.G., Jarrett D.B., and Kupfer D.J. Sleep EEG and DST findings in anergic bipolar depression. Am J Psychiatry 146 (1989) 329-333
222. Furukawa T.A., Streiner D.L., and Young L.T. Antidepressant and benzodiazepine for major depression. Cochrane Database Syst Rev 1 (2002) CD001026
223. Dominguez R.A., Jacobson A.F., Goldstein B.J., and Steinbook R.M. Comparison of triazolam and placebo in the treatment of insomnia in depressed patients. Curr Ther Res 36 (1984) 856-865
224. Scharf M.B., Hirschowitz J., Zemlan F.P., Lichstein M., and Woods M. Comparative effects of limbitrol and amitriptyline on sleep efficiency and architecture. J Clin Psychiatry 47 (1986) 587-591
225. Nolen W.A., Haffmans P.M., Bouvy P.F., and Duivenvoorden H.J. Hypnotics as concurrent medication in depression. A placebo-controlled, double-blind comparison of flunitrazepam and lormetazepam in patients with major depression, treated with a (tri)cyclic antidepressant. J Affect Disord 28 (1993) 179-188
226. Asnis G.M., Chakraburtty A., DuBoff E.A., Krystal A., Londborg P.D., Rosenberg R., et al. Zolpidem for persistent insomnia in SSRI-treated depressed patients. J Clin Psychiatry 60 (1999) 668-676
227. Smith W.T., Londborg P.D., Glaudin V., and Painter J.R. Short-term augmentation of fluoxetine with clonazepam in the treatment of depression: a double-blind study. Am J Psychiatry 155 (1998) 1339-1345
228. Smith W.T., Londborg P.D., Glaudin V., and Painter J.R. Short-term augmentation of fluoxetine with clonazepam in the treatment of depression: a double-blind study. Am J Psychiatry 155 (1998) 1339-1345